Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
HKSE - Delayed Quote HKD

TYK Medicines, Inc (2410.HK)

Compare
29.750
-1.250
(-4.03%)
As of 10:33:32 AM GMT+8. Market Open.
All numbers in thousands
Download
Breakdown
12/31/2023
12/31/2022
Total Assets
573,138
558,361
Total Liabilities Net Minority Interest
1,453,171
1,059,110
Total Equity Gross Minority Interest
-880,033
-500,749
Total Capitalization
-884,480
-505,940
Common Stock Equity
-884,480
-505,940
Capital Lease Obligations
41,729
55,950
Net Tangible Assets
-1,006,427
-635,583
Working Capital
-1,067,270
-687,510
Invested Capital
-884,480
-505,940
Tangible Book Value
-1,006,427
-635,583
Total Debt
41,729
55,950
Share Issued
370,835.818
370,835.818
Ordinary Shares Number
370,835.818
370,835.818
12/31/2022 - 8/20/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2105.HK Laekna, Inc.
11.980
-5.37%
 
2171.HK CARsgen Therapeutics Holdings Limited
13.020
+1.72%
 
2563.HK Beijing Biostar Pharms Co Ltd
16.820
-4.86%
 
2566.HK Hangzhou Jiuyuan Gene
7.130
-0.42%
 
2142.HK HBM Holdings Limited
5.350
-2.37%
 
1952.HK Everest Medicines Limited
45.550
+1.00%
 
1548.HK GENSCRIPT BIO
13.700
+3.63%
 
1873.HK VIVA BIOTECH
1.500
-5.66%
 
1672.HK ASCLETIS-B
5.650
-6.30%
 
AXSM Axsome Therapeutics, Inc.
137.75
+6.70%